Morrissey et al. targeted the screening biomarkers aquaporin-1 (AQP-1) and perilipin-2 (PLIN2) to detect and diagnose ccRCC and papillary renal cell carcinoma (pRCC) [48]. Here, PLIN2 is linked to nonpapillary renal cell carcinoma.